Back to Search Start Over

A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada

Authors :
Aylsworth, Laura
Manca, Terra
Dubé, Ève
Labbé, Fabienne
Driedger, S. Michelle
Benzies, Karen
MacDonald, Noni
Graham, Janice
MacDonald, Shannon E.
Source :
Human Vaccines & Immunotherapeutics; November 2022, Vol. 18 Issue: 6
Publication Year :
2022

Abstract

ABSTRACTStructural and systemic inequalities can contribute to susceptibility to COVID-19 disease and limited access to vaccines. Recognizing that Racialized and Indigenous Peoples may experience unique barriers to COVID-19 vaccination, this study explored early COVID-19 vaccine accessibility, including barriers and potential solutions to vaccine access, for these communities in Canada. We conducted semi-structured interviews about challenges to accessing COVID-19 vaccination with Racialized and Indigenous Peoples, including linguistic minorities and newcomers, in Spring 2021, just as COVID-19 vaccines were becoming more widely available in Canada. Participants were purposely selected from respondents to a Canadian national online survey. Three researchers analyzed the interviews for emergent themes using a descriptive content analysis approach in NVivo. At the time of the interview, interview participants (N = 27) intended to receive (n = 15) or had received (n = 11) at least one vaccine dose, or did not state their status (n = 1). Participants described multiple barriers to COVID-19 vaccination that they personally experienced and/or anticipated they or others could experience – including technology requirements, language barriers, lack of identification documentation, and travel challenges – as well as related solutions. These were organized into three broad categories: 1) COVID-19 disease and vaccination information, 2) vaccination booking procedures, and 3) vaccination sites. These structural and systemic barriers during the initial months of vaccine rollout substantially restricted participants’ COVID-19 vaccination access, even when they were eager to get vaccinated, and should be addressed early in vaccine rollouts to facilitate optimal uptake for everyone everywhere

Details

Language :
English
ISSN :
21645515 and 2164554X
Volume :
18
Issue :
6
Database :
Supplemental Index
Journal :
Human Vaccines & Immunotherapeutics
Publication Type :
Periodical
Accession number :
ejs61376849
Full Text :
https://doi.org/10.1080/21645515.2022.2129827